HSD103 Evolution 2019-2020 of Immune Checkpoint Inhibitors (ICI) Administration in Hospitalization at Home (HAH) for Cancer Patients in France: Descriptive Analysis From the French Public Health Insurance Database (PMSI)

Autor: M Pierre, P Lemeille, B Jouaneton, FE Cotte, M Chartier, H Lemasson, AF Gaudin

Publikováno v: Value in Health. 25:S293

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1fe430e999cd589b57edc5794c77f9ac
https://doi.org/10.1016/j.jval.2022.09.1446

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)

Autor: V. Grumberg, François-Emery Cotté, Anne-Françoise Gaudin, B. Jouaneton, Romain Corre, Matteo Giaj Levra, Jean-Baptiste Assié, C. Calvet, Christos Chouaid

Publikováno v: Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, SAGE Journals, 2020, 12, ⟨10.1177/1758835920967237⟩
Therapeutic Advances in Medical Oncology, 2020, 12, ⟨10.1177/1758835920967237⟩
Therapeutic Advances in Medical Oncology, Vol 12 (2020)

Objective: To describe long-term outcomes of patients treated with nivolumab for advanced non-small cell lung cancer (aNSCLC) in everyday clinical practice in France, with a focus on patients aged ⩾80 years, patients with renal impairment and patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::868cc43312377be7d555836da9b7641e
https://hal.sorbonne-universite.fr/hal-03018987/file/1758835920967237.pdf

POSA235 Immune Checkpoint Inhibitors (ICI) Infusion at Home for Cancer Patients: An Analysis of the French National Hospital Database (PMSI)

Autor: H Lemasson, N Tchouen, B Jouaneton, P Lemeille, AF Gaudin, FE Cotte

Publikováno v: Value in Health. 25:S154

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d2686baa561e224b7f7f4abe6a41e4c
https://doi.org/10.1016/j.jval.2021.11.750

Re-challenge de l’immunothérapie en vie réelle après un traitement par nivolumab dans le traitement du cancer bronchique non à petites cellules (CBNPC) à un stade avancé en France (étude UNIVOC)

Autor: Romain Corre, Christos Chouaid, V. Grumberg, Anne-Françoise Gaudin, Jean-Baptiste Assié, C. Calvet, M. Giaj Levra, R. Jolivel, B. Jouaneton, François-Emery Cotté

Publikováno v: Revue des Maladies Respiratoires Actualités. 12:45-46

Introduction Les donnees en vie reelle peuvent completer celles des essais cliniques afin d’optimiser la prise en charge courante du CBNPC. Apres l’arret du nivolumab, peu de donnees existent concernant les pratiques, les options therapeutiques e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee7e02fc8b27558778de48467489e6c2
https://doi.org/10.1016/j.rmra.2019.11.078

Evaluation of 'Sophia Diabetes', a diabetic patient support programme, 8 years after its initiation

Autor: B. Jouaneton, M. Cavillon, Alexandre Vainchtock, R. Cash, C. Leboucher, E. Gomez, A Aguade

Publikováno v: European Journal of Public Health. 29

Background “Sophia Diabetes” is a personalized diabetic patient support program piloted by French National Health Insurance, launched experimentally in 10 primary health insurance funds in March 2008, extended in 2010 and then generalized to all

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::93447df308df260b0ff5626fbe73f505
https://doi.org/10.1093/eurpub/ckz187.213